| 注册
首页|期刊导航|国际医药卫生导报|联合疗法治疗慢性特发性荨麻疹的疗效观察

联合疗法治疗慢性特发性荨麻疹的疗效观察

何金锡 蔡志凌 黄文富

国际医药卫生导报2009,Vol.15Issue(6):76-77,83,3.
国际医药卫生导报2009,Vol.15Issue(6):76-77,83,3.DOI:10.3760/cma.j.issn.1007-1245.2009.06.032

联合疗法治疗慢性特发性荨麻疹的疗效观察

Therapeutic observation of the effect of combining therapy on chronic idiopathic urticaria

何金锡 1蔡志凌 2黄文富1

作者信息

  • 1. 516001,惠州市中心人民医院药剂科
  • 2. 516001,惠州市皮肤病防治研究所
  • 折叠

摘要

Abstract

Objective To observe the therapeutic effect and side effect of mizolastine combined with tripterygium and ranitidine in treating chronic idiopathic urticaria. Methods 92 patients with chronic idiopathic urticaria were divided into three groups randomly. The treatment group(A) were treated with mizolastine com-bined with tripterygium and ranitidine. The control group 1 (B)were treated with mizolastine combined with tripterygium. The control group 2(C) were treated with mizolastine. The treatment lasted for 4 weeks. Result The effective rates of the three groups were 90.10%,80% and 72%, respectively.The cure rates of the three groups were 52.38%,36% and 32%, respectively. There was statistically significant difference (P< 0.01 ). Conclusion Com-bining Therapy is effective and safe in treating chronic idiopathic urticaria.

关键词

咪唑斯汀/雷公藤多甙/雷尼替丁/慢性特发性荨麻疹

Key words

Mizolastine/Tripterygium/Ranitidine/Chronic idiopathic urticaria

分类

医药卫生

引用本文复制引用

何金锡,蔡志凌,黄文富..联合疗法治疗慢性特发性荨麻疹的疗效观察[J].国际医药卫生导报,2009,15(6):76-77,83,3.

国际医药卫生导报

1007-1245

访问量4
|
下载量0
段落导航相关论文